Bombay Oxygen FY26 net loss ₹324 cr; ₹25 dividend

Key development: Profit turns to loss in FY26

Bombay Oxygen Investments Limited reported a net loss of ₹324.06 crore for the financial year ended March 31, 2026, reversing the net profit of ₹1,750.59 crore posted in FY25. The change was driven mainly by losses linked to fair value changes in financial assets, according to the audited results approved by the board. Even with the loss, the board recommended a final dividend of ₹25 per equity share of face value ₹100 each, subject to shareholder approval. The company also set key dates for the Annual General Meeting (AGM) process, including the dividend record date and the book closure period.

Board approval and regulatory disclosure

The audited standalone financial results were approved by the Board of Directors on May 27, 2026. The company had earlier informed BSE that a board meeting would be held on May 27, 2026 under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The agenda included consideration of audited standalone results for the quarter and year ended March 31, 2026, and a recommendation of dividend, if any.

The company also disclosed that the trading window for designated persons was closed from April 1, 2026 to May 29, 2026 (inclusive). These disclosures place the results and dividend proposal within the standard compliance framework followed by listed companies.

What pulled down FY26 results: fair value changes

Bombay Oxygen said its FY26 performance was heavily impacted by a net loss on fair value changes of financial assets of ₹467.82 crore for the year. This line item mattered because the company’s total income for FY26 turned negative at ₹182.43 crore, compared with a positive total income of ₹2,090.39 crore in FY25.

The numbers indicate that valuation movements in financial assets were a dominant factor in the year’s reported outcome. While the company recorded higher dividend income during FY26, it was not enough to offset the overall impact of fair value losses and higher expenses.

Income and expenses: dividend income up, costs also higher

Dividend income increased to ₹271.43 crore in FY26 from ₹226.52 crore in the prior year. Total expenses rose to ₹205.01 crore from ₹182.74 crore in FY25, with the company indicating the increase was primarily due to higher other expenses.

The combination of higher expenses and negative total income shaped the final net loss for FY26. The company’s audited financial results were accompanied by an Independent Auditor’s Report that was free from qualifications.

Q4FY26 snapshot: deeper quarterly loss

For the quarter ended March 31, 2026, Bombay Oxygen reported a net loss of ₹3,140.75 crore. This compared with a net loss of ₹1,230.14 crore in the corresponding quarter of the previous year.

Total income for the quarter was negative ₹3,541.48 crore. The company attributed this primarily to a net loss on fair value changes of financial assets of ₹3,565.12 crore during the period. The quarterly figures underline how sharply fair value movements influenced the quarter’s reported performance.

Dividend details and key shareholder dates

Despite the FY26 net loss, the Board of Directors recommended a dividend of ₹25 per equity share of ₹100 each. The proposal requires shareholder approval at the ensuing AGM.

The board fixed Tuesday, August 18, 2026 as the record date for determining shareholders eligible for the final dividend and the AGM. The register of members will remain closed from August 19, 2026 to August 25, 2026.

The company’s 65th Annual General Meeting is scheduled for August 25, 2026 and will be held via video conferencing.

Table: FY26 vs FY25 and Q4 comparison

Market cues: stock move and seasonality note

The stock price was reported to have moved up by 3.69% from its previous close of ₹19,505.15, with the last traded price cited at ₹20,225.00. Separately, the data set also noted that in 9 out of 16 years, Bombay Oxygen Investments Limited has delivered negative returns in May.

While the results and dividend recommendation were the main corporate triggers, the price move and the seasonality statistic provide additional context for how the stock is tracked by market participants.

IEPF notice: deadline for unclaimed dividends

Bombay Oxygen also issued a notice for mandatory transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority for shareholders with unclaimed dividends for seven consecutive years, covering financial years 2018-19 to 2024-25. Shareholders were asked to claim the dividends by August 26, 2026 by submitting the required documents to the company’s Registrar and Transfer Agent (RTA).

The company stated that failure to claim by the deadline will result in automatic transfer of shares to the IEPF Authority without further notice. It also explained that shareholders can later reclaim unclaimed dividends and transferred shares by applying online through web-Form IEPF-5 on the Ministry of Corporate Affairs website.

Market impact: what the numbers signal

The reported FY26 net loss of ₹324.06 crore and the sharply negative quarterly income in Q4 highlight how fair value changes affected reported earnings. The company specifically disclosed fair value losses of ₹467.82 crore for FY26 and ₹3,565.12 crore for Q4, linking these items directly to the negative income figures.

At the same time, dividend income increased to ₹271.43 crore, and the board still recommended a ₹25 per share dividend. For investors, the immediate, factual takeaway is the contrast between accounting-driven fair value losses and a dividend proposal, along with clearly defined AGM and record-date timelines.

Conclusion

Bombay Oxygen’s FY26 results marked a swing from FY25 profit to FY26 loss, primarily due to fair value changes in financial assets. Even so, the board proposed a ₹25 per share dividend, with August 18, 2026 set as the record date and the AGM scheduled for August 25, 2026. Separately, shareholders with unclaimed dividends for FY2018-19 to FY2024-25 have a stated deadline of August 26, 2026 to avoid transfer of shares to the IEPF Authority.